J.-P. Zarski

1.4k total citations · 1 hit paper
14 papers, 719 citations indexed

About

J.-P. Zarski is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, J.-P. Zarski has authored 14 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 3 papers in Genetics. Recurrent topics in J.-P. Zarski's work include Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). J.-P. Zarski is often cited by papers focused on Hepatitis C virus research (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). J.-P. Zarski collaborates with scholars based in France, Belgium and Netherlands. J.-P. Zarski's co-authors include Marielle Cohard, P Opolon, Thierry Poynard, Thierry Thévenot, Vincent Leroy, Philippe Mathurin, Bertrand Nalpas, Marc Bourlière, Armand Abergel and Albert Tran and has published in prestigious journals such as Hepatology, Journal of Medical Virology and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

J.-P. Zarski

12 papers receiving 684 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration

1996 573 citations Thierry Poynard, Vincent Leroy et al. Hepatology profile →

Peers

Countries citing papers authored by J.-P. Zarski

Since Specialization

Citations

This map shows the geographic impact of J.-P. Zarski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-P. Zarski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-P. Zarski more than expected).

Fields of papers citing papers by J.-P. Zarski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-P. Zarski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-P. Zarski. The network helps show where J.-P. Zarski may publish in the future.

Co-authorship network of co-authors of J.-P. Zarski

This figure shows the co-authorship network connecting the top 25 collaborators of J.-P. Zarski. A scholar is included among the top collaborators of J.-P. Zarski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-P. Zarski. J.-P. Zarski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies 2008 ·European Journal of Clinical Microbiology & Infectious Diseases ·B. Chumpitazi, Laurence Bouillet, M Drouet, Lauriane Kühn, (unknown), J.-P. Zarski, Christian Drouet	7
2	O.079 Novel sustained release formulation of IFN α-2b improves tolerability and demonstrates potent viral load reduction in a phase I/II HCV clinical trial 2006 ·Journal of Clinical Virology ·Christian Trépo, R. Meyrueix, M. Travis Maynard, Roman Rouzier, Marc Bourlière, Yves Donazzolo, J.-P. Zarski, Roger Kravtzoff	2
3	Cellular glycosaminoglycan as a target for virus adsorption 2001 ·Virologie ·Raphaële Germi, Jean‐Marc Crance, D. Garín, J.-P. Zarski, Emmanuel Drouet	0
4	Rôle des glycosaminoglycanes dans l'adsorption des virus sur les cellules-hôtes 2001 ·Virologie ·Raphaële Germi, Jean‐Marc Crance, (unknown), J.-P. Zarski, Emmanuel Drouet	1
5	Transplantation hépatique avec un greffon prélevé chez un greffé cardiaque en état de mort cérébrale 2000 ·Annales de Chirurgie ·C. Arvieux, Christian Létoublon, (unknown), Dominique Pasquier, (unknown), D. Barn�oud, (unknown), R Barnoud, (unknown), (unknown), Eve Borel, (unknown), Jacques Pirenne, J.-P. Zarski	1
6	Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C 2000 ·Hepatology ·(unknown), Bertrand Nalpas, Marc Bourlière, Patrice Couzigou, Albert Tran, Armand Abergel, J.-P. Zarski, Pierre Berthelot, (unknown)	47
7	Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis 2000 ·Journal of Medical Virology ·(unknown), Kaveh Samii, Laura Rubbia‐Brandt, Rafael Quadri, Pierre‐Jean G. Malé, J.-P. Zarski, (unknown), Emile Giostra, Photis Beris, Antoine Hadengue	42
8	Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration breakdown → 1996 ·Hepatology ·Thierry Poynard, Vincent Leroy, Marielle Cohard, Thierry Thévenot, Philippe Mathurin, P Opolon, J.-P. Zarski	573
9	[Is there a relationship between the presence of autoantibodies or mixed cryoglobulinemia and the clinical and histological characteristics of chronic viral hepatitis C?]. 1994 ·PubMed ·A Rolachon, Renaud Du Pasquier, M Girard, J Arvieux, Philippe Bichard, Jean‐Claude Bensa, J.-P. Zarski	9
10	[Significance of isolated anti-HBs antibodies in subjects not vaccinated against hepatitis B viruses]. 1991 ·PubMed ·F. Driss, J.-P. Zarski, AM Couroucé, (unknown), C. Bréchot, P. Berthelot, François Tron, Bertrand Nalpas	2
11	An Epidemiological and Clinical Study of Transaminase Levels and Hepatitis B Antibodies in 1,100 Blood Donors 1989 ·Vox Sanguinis ·F. Driss, B Boboc, J.-P. Zarski, (unknown), Stanislas Pol, (unknown), Ohvanesse G. Ekindjian, Anne Couroucé, Christian Bréchot, P. Berthelot, Bertrand Nalpas	7
12	Comparison of a quantitative standardized HBV-DNA assay and a classical spot hybridization test in chronic active hepatitis B patients undergoing antiviral therapy 1989 ·Research in Virology ·J.-P. Zarski, Mary C. Kuhns, (unknown), Françoise Degos, Solko W. Schalm, Pierre Tiollais, Christian Bréchot	19
13	[Extrahepatic digestive surgery in cirrhotic patients: mortality, morbidity and preoperative prognostic factors]. 1988 ·PubMed ·J.-P. Zarski, Philippe Bichard, (unknown), (unknown), (unknown), (unknown)	9
14	[What about the theory of false neurotransmitters in the hepatic encephalopathy of the cirrhotic patient?]. 1983 ·PubMed ·Michel Doffoël, J.-P. Zarski, Jacques Marescaux, (unknown)	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact